Selects: How LSD Works

Episode Summary

Executive Summary: The episode is a wide-ranging, myth-busting history of LSD: its accidental discovery by Albert Hofmann, early therapeutic promise, cultural explosion, and subsequent criminalization. The hosts emphasize that many fears about acid—brain damage, chromosomal damage, flashbacks, and deadly overdoses—are overstated or false, while modern brain imaging and clinical research suggest real potential for psychiatry, end-of-life care, and treatment of addiction.

Main Topics: Albert Hofmann’s discovery of LSD (Priority: 5/5): The show traces LSD’s origin at Sandoz, where Hofmann synthesized LSD-25 while studying ergot compounds, accidentally absorbed it, and later deliberately dosed himself to confirm the effects—creating Bicycle Day. Medical promise and early psychedelic therapy (Priority: 5/5): The hosts discuss LSD’s mid-century use in psychiatry, including psychedelic therapy in the U.S. and lower-dose approaches in Europe, along with anecdotes like Cary Grant’s positive experiences. Myths, hysteria, and prohibition (Priority: 5/5): A major theme is debunking misconceptions: LSD does not damage chromosomes, cause holes in the brain, or reliably produce terrifying hallucinations; public panic and media narratives helped drive criminalization and shut down research. How LSD affects the brain and experience (Priority: 5/5): The episode explains trip phenomenology—set and setting, time distortion, ego dissolution, sensory changes, and emotional swings—then connects it to newer findings about thalamic gating, brain network connectivity, and the default mode network. Safety, overdose, and flashbacks (Priority: 4/5): The hosts examine the evidence for lethal overdose, behavioral risks, and acid flashbacks, concluding that classic flashbacks are largely mythologized, while HPPD and other psychological effects are more plausible explanations. Cultural figures and counterculture (Priority: 4/5): Timothy Leary, Ken Kesey, Owsley Stanley, and Grateful Dead culture are presented as key forces shaping LSD’s public image, with Leary especially criticized for turning legitimate research into countercultural branding. Modern revival and microdosing (Priority: 4/5): The discussion closes with renewed scientific interest, small clinical studies, and the Silicon Valley microdosing trend, alongside warnings about adulterants like NBOMe and the need for more rigorous research.

Key Arguments: LSD was discovered accidentally but proved unusually powerful, suggesting major untapped scientific value rather than mere recreational novelty. Public fears about LSD were amplified by authorities and media, often using exaggerated or false claims that hindered serious research. Modern studies indicate LSD can meaningfully alter brain connectivity, supporting reports of ego dissolution and changes in self-perception. The strongest evidence today points to therapeutic promise in mental health, addiction, and end-of-life care, especially when used in controlled settings. Classic urban legends—chromosome damage, brain holes, stored acid flashbacks, and inevitable psychosis—are not supported by the evidence presented. LSD is difficult to classify as addictive because its effects are unpredictable and tolerance develops rapidly, making compulsive daily use uncommon. The risks that do exist are often behavioral or due to misrepresented substances, not LSD itself; adulterants and reckless environments are the bigger dangers.

Data Points: Year of first synthesis: 1938 - Hofmann created LSD-25 while working with ergot compounds at Sandoz Date of first self-experiment: April 18, 1943 - Hofmann accidentally absorbed LSD, experiencing the first acid trip Bicycle Day self-test dose: 250 micrograms - Hofmann’s deliberate dose the next day, taken orally Typical modern minimum dose: About 25 micrograms - Discussed as roughly one-tenth of Hofmann’s 250 microgram dose Trip duration: 7 to 12 hours - Typical LSD experience described in the episode Onset time: 30 to 60 minutes - Time between ingestion and noticeable effects Peak timing: About halfway through the trip - The strongest effects occur mid-trip U.S. patients treated in early therapeutic era: 40,000 doses/patients - The episode states 40,000 doses were given in the U.S. alone Sandoz marketing year: 1947 - LSD was marketed as Delysid Year LSD became illegal in the U.S.: 1966 - The episode notes criminalization in mid-1960s NIMH position year: 1974 - National Institute of Mental Health said LSD had no therapeutic value Standard blotter square size: About 1/4 inch by 1/4 inch - Used to describe blotter acid dosing sheets Blotter capacity: Up to 900 doses per sheet - A single sheet can contain many doses Minimum dose weight: A quarter microgram - Described as approximately the weight of two grains of salt Reported extreme ingestion case: 7 milligrams - A 1975 party incident where people thought they were snorting cocaine Reported survival case: 40 milligrams - A person reportedly survived ingesting 40 mg of LSD Clinical trial size: 20 volunteers - Imperial College of London brain-imaging study Terminal illness study size: 12 patients - A 2014 U.S. study involving terminally ill cancer patients Research recall window: Within a few years - Sandoz recalled stocks and handed them to NIMH after stopping production

Pivotal Quotes: "I did not choose LSD. LSD found and called me." — Albert Hofmann: A quote used to illustrate Hofmann’s sense that the compound seemed to discover him "LSD simultaneously creates hyper-connections across the brain, allowing the functions of seemingly unrelated regions of the brain to ooze into one another." — Narrator/hosts quoting researchers: Summarizing modern brain-imaging findings on what LSD does neurologically "Tune in, turn on, drop out." — Timothy Leary: Referenced as the slogan that helped shape public perception of LSD and counterculture

Implications: The episode suggests LSD deserves renewed, carefully controlled scientific study. For listeners, the takeaway is to separate folklore from evidence: the drug has real risks, but also credible therapeutic promise and far less mystical danger than its reputation suggests.